Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος:	Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study
Συγγραφείς:	Alcázar-Navarrete, Bernardino^{Aff1, Aff2}, Figueira-Gonçalves, Juan Marco^Aff3, Blanco Cid, Nagore^Aff4, Bruguera Avila, Nuria^Aff5, Bernabeu Mora, Roberto^Aff6, Fuster Gomila, Antonia^Aff7, Galera Martínez, Raúl^Aff8, García Clemente, Marta M.^Aff9, Granados, Galo^Aff10, Khadour Khadour, Hassan^Aff3, Márquez-Martín, Eduardo^Aff11, Murga Arizabaleta, Igor^Aff12, Velasco Garrido, Jose Luis^Aff13, Corregidor-García, Carmen^Aff14, Fitas, Eunice^Aff14, Sánchez-Covisa, Joaquín^{Aff14, IDs4103002600366x_cor1}
Πηγή:	Pulmonary Therapy. 12(2):667-689
Βάση Δεδομένων:	Springer Nature Journals

Περιγραφή
ISSN:	23641754 23641746
DOI:	10.1007/s41030-026-00366-x